Sarantis schedules October 21 results for Sarantis stock

Published on 10/20/2026 at 12:33 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Sarantis reported H1 sales of EUR 308.30 million. Sarantis stock costs EUR 10.98 on October 20, 2026 at a EUR 699.4 million market value.

Results and operating scale

Sarantis has its nine-month results scheduled for October 21, 2026.
First-half 2026 sales were EUR 308.30 million and adjusted EBITDA was EUR 48.50 million.
Sarantis stock was trading at EUR 10.98 at 12:29 p.m. CEST on October 20, 2026 at Lang & Schwarz.

Hellenic Petroleum, GRS204003008, Illustration mit AI erstellt.

Sarantis stock (ISIN GRS204003008) was trading at EUR 10.98 at Lang & Schwarz on October 20, 2026, at 12:29 p.m. CEST. The company is approaching its nine-month results date on October 21, 2026, listed by Economicomarkets. The upcoming release gives investors a near-term test of sales momentum and profitability after a mixed first half.

First-half sales set the base

For the first half of 2026, Sarantis reported net sales of EUR 308.30 million and adjusted EBITDA of EUR 48.50 million. The figures are identified in the company data summarized by xrimatirio.com, which also lists an adjusted EBITDA margin of 15.50 percent for the period.

The same first-half review puts net debt at EUR 29.60 million on June 30, 2026, giving the October results a balance-sheet angle alongside revenue. The company operates across beauty, personal care, household products and private-label goods, with sales outside Greece accounting for 73.50 percent of first-half revenue.

What will October 21 clarify?

The key question is whether the nine-month figures support a recovery in operating margins. Newmoney reported on September 22, 2026 that Eurobank Equities cut its target from EUR 16.00 to EUR 15.10 while retaining a Buy rating. The report said adjusted EBIT for 2026 was expected to rise 2.00 percent, with the margin at 11.20 percent.

Three dated signals for investors

On September 8, 2026, the first-half release showed EUR 308.30 million in sales and EUR 48.50 million in adjusted EBITDA. On September 21, 2026, FMR LLC reached 10.00 percent of voting rights, equal to 6,370,000 voting rights, according to Mononews. The current event is the October 21, 2026 nine-month results release.

The next dated event is October 21, 2026, the nine-month results release. The figures should show whether pricing, product mix and operating costs are moving closer to the margin recovery described by Eurobank Equities.

Stock price and investor context

Sarantis was trading at EUR 10.98 at Lang & Schwarz on October 20, 2026 at 12:29 p.m. CEST. Finance data put the company's market capitalization at EUR 699.4 million on October 20, 2026, while the Athens listing identifies the ticker as SAR.AT. The company is listed on the Athens Exchange and operates in the household and personal-products industry.

The further course of trading is shown by the continuously updated real-time quote of Sarantis stock.